JPMorgan Chase & Co. Cuts Clorox (NYSE:CLX) Price Target to $114.00

Clorox (NYSE:CLX) had its price target cut by JPMorgan Chase & Co. from $120.00 to $114.00 in a report issued on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 4.37% from the company’s previous close.

CLX has been the topic of several other research reports. Bank of America dropped their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Friday, January 9th. Rothschild & Co Redburn lowered their price target on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Barclays reduced their price objective on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating for the company in a research note on Tuesday, November 4th. Finally, Morgan Stanley lowered their target price on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $122.25.

Clorox Stock Down 1.8%

NYSE:CLX traded down $2.01 on Friday, reaching $109.22. 385,209 shares of the stock traded hands, compared to its average volume of 2,088,099. The company’s fifty day simple moving average is $103.07 and its 200 day simple moving average is $115.39. The company has a market capitalization of $13.32 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 0.55 and a beta of 0.58. Clorox has a 12 month low of $96.66 and a 12 month high of $164.22. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.Clorox’s revenue was down 18.9% compared to the same quarter last year. During the same period last year, the firm posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities analysts predict that Clorox will post 7.15 EPS for the current fiscal year.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.63% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Nomura Asset Management Co. Ltd. grew its position in Clorox by 9.0% during the second quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock valued at $40,285,000 after buying an additional 27,639 shares during the period. Simplicity Wealth LLC lifted its stake in Clorox by 157.3% in the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,198 shares in the last quarter. Hudson Bay Capital Management LP acquired a new position in shares of Clorox during the 2nd quarter valued at about $8,568,000. Vise Technologies Inc. acquired a new position in Clorox in the 2nd quarter valued at about $328,000. Finally, Brookstone Capital Management lifted its holdings in Clorox by 1,395.4% in the third quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock valued at $11,631,000 after acquiring an additional 88,024 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.